True North Copper Raises A$20 Million to Complete Mt Oxide Payment and Accelerate Growth

Capital Raise Secures Final Mt Oxide Payment

True North Copper (ASX:TNC) has successfully raised A$18 million through a placement of nearly 49 million shares at $0.37 each, a price representing a 14% discount to the last close. The raise was upsized from an initial $15 million after strong investor demand, with cornerstone support from major shareholder Tembo Capital Holdings UK Ltd and participation from new institutional investors. Alongside this, the company plans a Share Purchase Plan (SPP) capped at A$2 million at the same price, offering eligible shareholders a chance to participate without brokerage costs.

The proceeds will primarily fund the final A$7.5 million deferred consideration payment to Perilya, completing True North’s acquisition of the Mt Oxide Project. This payment clears a significant milestone in the company’s growth journey, solidifying ownership of its flagship asset.

Accelerating Growth at Mt Oxide and Cloncurry

Beyond settling acquisition obligations, the capital injection will fuel ongoing exploration and technical work at Mt Oxide’s Aquila deposit through 2027. Drilling aims to expand the mineralised system along strike and at depth, while refining the geometry and continuity of higher-grade copper zones. These efforts align with True North’s strategy to grow the Mt Oxide resource base and enhance its development potential.

Meanwhile, the Cloncurry Copper Project is advancing towards a Pre-Feasibility Study (PFS) targeted for late Q4 2026. The PFS will assess development options and potential ore reserves, supported by technical studies and evaluation of optimisation opportunities. This dual focus on Mt Oxide and Cloncurry underpins True North’s three-platform growth strategy: Grow, Develop, and Discover.

Share Placement Structure and Investor Support

The placement will be issued in two tranches. Tranche 1, raising A$12.2 million through approximately 33.1 million shares, utilises existing placement capacity and is expected to settle by 21 August 2026. Tranche 2, comprising about 15.6 million shares to raise A$5.8 million, awaits shareholder approval at a general meeting anticipated in October 2026. This tranche includes a A$2 million commitment from Tembo Capital and A$500,000 from Non-Executive Chairman Paul Cronin.

The SPP, opening on 25 August and closing on 10 September 2026, offers eligible shareholders the opportunity to subscribe for up to A$30,000 worth of shares at the placement price. However, the SPP is not underwritten and may be scaled back at the company’s discretion, introducing some uncertainty around total proceeds raised from this initiative.

Strategic Implications and Upcoming Catalysts

Managing Director Andrew Mooney highlighted the funding as a critical step to maintain momentum across True North’s copper portfolio. The company’s 2026 drilling campaign at Aquila has already expanded the high-grade shoot and enhanced geological understanding, with further assay results expected in the coming months. These drilling results will be key to defining resource extensions and unlocking value at Mt Oxide.

At Cloncurry, the upcoming PFS will provide a clearer pathway for development, potentially unlocking near-term cash flow. The combination of these projects, supported by regional exploration targeting Tier-1 IOCG systems such as Chumvale and Salebury, positions True North to build scale and quality in its copper assets.

Investors should watch for the shareholder meeting outcome regarding Tranche 2 placement approval, subscription levels in the SPP, and ongoing assay updates from Mt Oxide. The timing and success of the Cloncurry PFS will also be pivotal in shaping the company’s development trajectory.